logo
Select company
Select metric
$ 99.84MNet Cash Flow - Financing
VS
Market
17
Sector
14
Industry
18
History
67
$ 37.25Close
$ 10.84 - $ 37.25 52-Week Range
Ticker Information

Ticker

INBX

Company Name

INHIBRX BIOSCIENCES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

INHIBRX BIOSCIENCES INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

INBX - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ 99.84M
3/31/2025$ 132.79M
12/31/2024$ 71.68M
12/31/2023$ 201.96M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • INHIBRX BIOSCIENCES INC's latest trailing twelve months (TTM) CF - Financing stands at $ 201.96M.
  • Over the past 5 years, INHIBRX BIOSCIENCES INC's average CF - Financing has been $ 126.57M.
  • The median CF - Financing for INHIBRX BIOSCIENCES INC during this period was $ 116.31M
  • INHIBRX BIOSCIENCES INC reached its highest CF - Financing over the past 5 years at $ 201.96M.
  • The lowest CF - Financing recorded by INHIBRX BIOSCIENCES INC in the same timeframe $ 71.68M

INHIBRX BIOSCIENCES INC's CF - Financing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Financing Benchmarks
CompanyCF - Financing
NWBO : NORTHWEST BIOTHERAPEUTICS INC $ 51.74MRNAC : CARTESIAN THERAPEUTICS INC $ 117.31MVSTM : VERASTEM INC $ 201.18MHUMA : HUMACYTE INC $ 100.76MOTLK : OUTLOOK THERAPEUTICS INC $ 33.31MABEO : ABEONA THERAPEUTICS INC $ 22.28MMREO : MEREO BIOPHARMA GROUP PLC $ -346KCATX : PERSPECTIVE THERAPEUTICS INC $ 11.08MPLUR : PLURI INC $ 9.53MDTIL : PRECISION BIOSCIENCES INC $ 25.64M

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

INBX - Net Cash Flow - Financing, Last 5 years

$ 71.68M

Minimum

Dec 31, 2024

$ 201.96M

Maximum

Dec 31, 2023

$ 126.57M

Average

$ 116.31M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.74M with a standard deviation of $ 119.11M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.23K
min$ -367.1M
max$ 366M
average$ -6.74M
median$ 314K
std$ 119.11M